Comparison of intravenous salbutamol (albuterol) and aminophylline in the treatment of acute asthmatic attacks
- PMID: 3898925
Comparison of intravenous salbutamol (albuterol) and aminophylline in the treatment of acute asthmatic attacks
Abstract
Our investigation supports the use of intravenous salbutamol as an alternative to aminophylline in the early stages of acute severe asthma. Salbutamol proved to be a marginally better bronchodilator and is likely to cause less gastrointestinal side effects than aminophylline, but tachycardia and generalized tremor are more frequent with this drug.